SlideShare ist ein Scribd-Unternehmen logo
1 von 43
Downloaden Sie, um offline zu lesen
Thyroid Neoplasms
Solitary Thyroid Nodule
• The majority of thyroid nodules are benign
and do not require removal.
• Therefore, it is of utmost importance to
determine which patients with solitary thyroid
nodule would benefit from surgery.
History
• Details regarding the nodule, such as
– time of onset, change in size,

• Associated symptoms, such as
– pain, dysphagia, dyspnea, or choking, should be
elicited.

• Pain is an unusual symptom and when
present, should raise suspicion for
– intrathyroidal hemorrhage in a benign
nodule, thyroiditis, or malignancy.

• Patients with medullary thyroid cancer may
complain of a dull, aching sensation.
History
• A hx of hoarseness is worrisome because it may
be secondary to malignant involvement of the
recurrent laryngeal nerves.
• Most importantly, patients should be questioned
regarding risk factors for malignancy,
– such as exposure to ionizing radiation and family
history of thyroid and other malignancies associated
with thyroid cancer.

• External Beam Radiation- The risk is maximum 20
to 30 years after exposure
• Family History
– is a risk factor for the development of both medullary
and nonmedullary thyroid cancer
– Familial medullary thyroid cancers occur in isolation
or in association with other tumors as part of multiple
endocrine neoplasia type 2 (MEN2) syndromes.
– Nonmedullary thyroid cancers can occur in association
with other known familial cancer syndromes such as
• Cowden's syndrome, Werner's (adult progeroid) syndrome,
and familial adenomatous polyposis.

– Nonmedullary thyroid cancers also can occur
independently of these syndromes.
Physical Examination
• Thyroid masses move with swallowing and failure to
observe the patient swallowing may lead one to miss a
large substernal goiter.
• The thyroid gland is best palpated from behind the patient
and with the neck in mild extension.
• The cricoid cartilage is an important landmark
– because the isthmus is situated just below it.

• Nodules that are hard, gritty, or fixed to surrounding
structures, such as to the trachea or strap muscles
– more likely to be malignant.

• The cervical chain of lymph nodes should be assessed as
well as the nodes in the posterior triangle.
• One should examine the patient for a Delphian node and
pyramidal lobe situated just above the thyroid isthmus and
cricoid cartilage.
Thyroid neoplasms
Diagnostic Tests
• Fine-Needle Aspiration Biopsy
– single most important test in the evaluation of patients with
thyroid masses
– can be performed with or without ultrasound guidance.
– Ultrasound guidance is recommended for
• nodules that are difficult to palpate and
• for complex, solid cystic nodules that recur after the initial aspiration.

• After FNA biopsy, the majority of nodules can be
categorized into the following groups: benign (65%),
suspicious (20%), malignant (5%), and nondiagnostic (10%).
• The incidence of false-positive results is approximately 1%
and false-negative results occur in approximately 3% of
patients.
• Nondiagnostic, it should usually be repeated.
– Bloody FNA biopsy may also be reported as nondiagnostic
and often indicates a follicular neoplasm.

• Benign lesions include cysts and colloid nodules. The
risk of malignancy in this setting is less than 3%.
• Suspicious cytology- The risk of malignancy is 10 to
20%.
– Most are follicular or Hürthle cell neoplasms.
– Diagnosis of malignancy in this situation relies on
demonstrating capsular or vascular invasion,
• features that cannot be determined via FNA biopsy.
• FNA biopsy is also less reliable in patients who
have a history of head and neck irradiation or a
family history of thyroid cancer,
– because of a higher likelihood of multifocal lesions.

• There is little or no value in repeating an FNA
biopsy for a follicular or Hürthle cell lesion,
• Repeat FNA biopsy can be useful for patients
when the cytology has some abnormalities that
suggest a papillary thyroid cancer, but not
enough to make this diagnosis.
Laboratory Studies
• Serum TSH- Most patients with thyroid nodules are
euthyroid.
– If a patient with a nodule is found to be hyperthyroid, the risk of
malignancy is approximately 1%.

• Serum Tg levels cannot differentiate benign from malignant
thyroid nodules unless the levels are extremely high,
– in which case metastatic thyroid cancer should be suspected.
– Useful in following patients who have undergone total
thyroidectomy for thyroid cancer
– For serial evaluation of patients undergoing nonoperative
management of thyroid nodules.

• Serum calcitonin levels should be obtained in patients with
medullary thyroid cancer or a family history of medullary
thyroid cancer (MTC) or MEN2.
Imaging
• Ultrasound is helpful for detecting nonpalpable thyroid
nodules,
– for differentiating solid from cystic nodules, and
– for identifying adjacent lymphadenopathy.
– It also provides a noninvasive and inexpensive method of
following the size of suspected benign nodules diagnosed by
FNA biopsy.

• CT and MRI are unnecessary in the routine evaluation of
thyroid tumors, except for large, fixed, or substernal
lesions.
• Scanning the thyroid with 123I or 99mTc is rarely
necessary, unless evaluating patients for "hot" or
autonomous thyroid nodules.
– currently recommended in the assessment of thyroid nodules
only in patients
– who have follicular thyroid nodules on FNA biopsy and a
suppressed TSH.
Management
• Malignant tumors are treated by thyroidectomy
• Simple thyroid cysts resolve with aspiration in
approximately 75% of cases, although some
require a second or third aspiration.
– Unilateral thyroid lobectomy is recommended
• If the cyst persists after three attempts at aspiration.
• for cysts greater than 4 cm in diameter
• for complex cysts with solid and cystic components, because
of higher incidence of malignancy (15%).

• When FNA biopsy is used in complex nodules, the
solid portion should be sampled.
• If a colloid nodule is diagnosed by FNA biopsy,
patients should still be observed with serial
ultrasound and Tg measurements.
– If the nodule enlarges, repeat FNA biopsy is often
indicated.
– l-thyroxine in doses sufficient to maintain a serum TSH
level between 0.1 and 1.0 µU/ mL may also be
administered.
• Most effective for nodules smaller than 3 cm.

– Previous irradiation of the thyroid gland or who has a
family history of thyroid cancer• total or near-total thyroidectomy
– High incidence of thyroid cancer (40%)
– and decreased reliability of FNA biopsy in this setting.
Papillary Carcinoma
• 80% of all thyroid malignancies in iodine-sufficient areas
• The predominant thyroid cancer in children and individuals
exposed to external radiation.
• Occurs more often in women, with a 2:1 female: male ratio;
• The mean age at presentation is 30 to 40 years.
• Most patients are euthyroid and present with a slowgrowing painless mass in the neck.
• Dysphagia, dyspnea, and dysphonia are usually associated
with locally advanced invasive disease.
• Lymph node metastases are common, especially in children
and young adults, and may be the presenting complaint.
• The so-called "lateral aberrant thyroid" almost always
denotes a cervical lymph node that has been invaded
by metastatic cancer.
• Suspicion of thyroid cancer often originates through
physical examination of the patient and a review of the
patient's history.
• Diagnosis is established by FNA biopsy of the thyroid
mass or lymph node.
• Distant metastases are uncommon at initial
presentation, but may ultimately develop in up to 20%
of patients.
• The most common sites are the lungs, followed by
bone, liver, and brain.
Pathology
• Gross - hard and whitish and remain flat on sectioning with
a blade, in contrast to normal tissue or benign nodular
lesions that tend to bulge.
– Macroscopic calcification, necrosis, or cystic change may be
apparent.

• Histologically- may exhibit papillary projections, a mixed
pattern of papillary and follicular structures, or a pure
follicular pattern (follicular variant).
• The diagnosis is established by characteristic cellular
features.
– Cells are cuboidal with pale, abundant cytoplasm,
– "grooving," crowded nuclei, and intranuclear cytoplasmic
inclusions, leading to the designation of Orphan Annie nuclei,
which allows diagnosis by FNA biopsy.
– Psammoma bodies, which are microscopic, calcified deposits
representing clumps of sloughed cells, may be present.
• Mixed papillary–follicular tumors and follicular variant of
papillary carcinoma are classified as papillary carcinomas
because they act biologically as papillary carcinomas.
• Multifocality - in up to 85% of cases. It is associated with an
increased risk of cervical nodal metastases
• Rarely invade adjacent structures such as the
trachea, esophagus, and recurrent laryngeal nerves.
• Other variants of papillary carcinoma (approximately 1% of
all papillary carcinomas) include
– tall cell, insular, columnar, diffuse sclerosing, clear
cell, trabecular, and poorly differentiated types.
– They are generally associated with a worse prognosis
Prognostic Indicators
• In general, patients with PTC have an excellent
prognosis with a greater than 95% 10-year survival
rate.
• AGES scoring system, which incorporates age,
histologic grade, extrathyroidal invasion and
metastases, and tumor size to predict the risk of dying
from papillary cancer.
• The MACIS scale- metastases, age at presentation,
completeness of original surgical resection,
extrathyroidal invasion, and size of original lesion
• AMES system
Papillary or Follicular Tumors
Stage
Younger than age 45 Years
I
II
Age 45 Years and older
I
II
III
IVA
IVB
IVC
Medullary Thyroid Cancer
Stage
I
II
III
IVA
IVB
IVC
Anaplastic Cancer
Stage
IVA
IVB
IVC

TNM
Any T, Any N, M0
Any T, Any N, M1
T1, N0, M0
T2, N0, M0
T3, N0, M0; T1-3, N1a, M0
T4a, N0-1a, M0; T1-4a, N1b, M0
T4b, Any N, M0
Any T, any N, M1
TNM
T1, N0, M0
T2-3, N0, M0
T1-3, N1a, M0
T4a, N0-1a, M0; T1-4a, N1b, M0
T4b, any N, M0
Any T, Any N, M1
TNM
T4a, Any N, M0
T4b, Any N, M0
Any T, Any M, M1
Definitions
•
•
•
•
•
•

Primary tumor (T)
TX = Primary tumor cannot be assessed
T0 = No evidence of primary tumor
T1 = Tumor ≤2 cm in diameter, limited to thyroid
T2 = Tumor >2 cm but <4 cm in diameter, limited to thyroid
T3 = Tumor >4 cm in diameter, limited to thyroid, or any
tumor with minimal extrathyroidal invasion
• T4a = Any size tumor extending beyond capsule to invade
subcutaneous soft tissue, larynx, trachea, esophagus, or
recurrent laryngeal nerve, or intrathyroidal anaplastic
cancer
• T4b = Tumor invading prevertebral fascia, or encasing
carotid artery or mediastinal vessels; or extrathyroidal
anaplastic cancer
• Regional lymph nodes (N)—include central,
lateral cervical, and upper mediastinal nodes
• NX = Regional lymph nodes cannot be assessed
• N0 = No regional lymph node metastasis
• N1 = Regional lymph node metastasis
• N1a = Metastases to level VI (pretracheal,
paratracheal, and prelaryngeal/Delphian lymph
nodes)
• N1b = Metastases to unilateral, bilateral, or
contralateral cervical or superior mediastinal LNs
Surgical Treatment
• Total or near-total thyroidectomy
Follicular Carcinoma
• Follicular carcinomas account for 10% of
thyroid cancers
• Occur more commonly in iodine-deficient
areas.
• The overall incidence of this tumor is,
probably as a result of iodine supplementation
and improved histologic classification.
• female: male ratio of 3:1,
• a mean age at presentation of 50 years.
• Usually present as solitary thyroid nodules,
– Occasionally with a history of rapid size
increase, and long-standing goiter.

• Pain is uncommon, unless hemorrhage into
the nodule has occurred.
• Unlike papillary cancers, cervical
lymphadenopathy is uncommon at initial
presentation (approximately 5%)
• Although distant metastases may be present.
• may be hyperfunctioning in less than 1% of cases,
– leading patients to present with signs and symptoms
of thyrotoxicosis.

• FNA biopsy is unable to distinguish benign
follicular lesions from follicular carcinomas.
• Therefore, preoperative diagnosis of cancer is
difficult unless distant metastases are present.
• Large follicular tumors (>4 cm) in older men are
more likely to be malignant.
Pathology
• Usually solitary lesions, the majority of which are
surrounded by a capsule.
• Histologically, follicles are present, but the lumen
may be devoid of colloid.
• Malignancy is defined by the presence of capsular
and vascular invasion.
• Minimally-invasive tumors
– appear grossly encapsulated
– but have evidence of microscopic invasion through the
tumor capsule and/or
– invasion into small- to medium-size vessels (venous
caliber) in or immediately outside the capsule, but not
within the tumor.
• Widely invasive tumors demonstrate evidence
of large-vessel invasion and/or broad areas of
tumor invasion through the capsule.
– They may, in fact, be unencapsulated.

• Tumor infiltration and invasion, as well as
tumor thrombus within the middle thyroid or
jugular veins, may be apparent at operation.
Surgical Treatment and Prognosis
• Patients diagnosed by FNA biopsy as having a follicular
lesion should undergo thyroid lobectomy because at least
80% of these patients will have benign adenomas.
• Some surgeons recommend total thyroidectomy in older
patients with follicular lesions larger than 4 cm because of
the higher risk of cancer in this setting (50%).
• Intraoperative frozen-section examination
– usually is not helpful,
– but should be performed
• when there is evidence of capsular or vascular invasion, or
• when adjacent lymphadenopathy is present.

• Total thyroidectomy should be performed when thyroid
cancer is diagnosed.
Hürthle Cell Carcinoma
• 3% of all thyroid malignancies
• Subtype of follicular thyroid cancer.
• Like follicular cancers, Hürthle cell cancers are
characterized by vascular or capsular invasion, and
therefore cannot be diagnosed by FNA biopsy.
• Tumors contain sheets of eosinophilic cells packed with
mitochondria, which are derived from the oxyphilic cells of
the thyroid gland.
• differ from follicular carcinomas in that they are more often
– multifocal and bilateral (approximately 30%),
– usually do not take up RAI (approximately 5%),
– are more likely to metastasize to local nodes (25%) and distant
sites
– are associated with a higher mortality rate (20% at 10 yrs).
• Hence, they are considered to be a separate class
of tumors by some surgeons.
• Management is similar to that of follicular
neoplasms,
– with lobectomy and isthmusectomy being sufficient
surgical treatment for unilateral Hürthle cell
adenomas.

• When Hürthle cell neoplasms are found to be
invasive on intraoperative, frozen-section, or
definitive paraffin-section histology,
– then total thyroidectomy should be performed.
• Radioiodine Therapy- benefit to patients with
differentiated thyroid cancer
• External Beam Radiotherapy and Chemotherapy
– External beam radiotherapy is occasionally required to
control unresectable, locally invasive or recurrent disease
– and to treat metastases in support bones to decrease the
risk of fractures.

• Single and multidrug chemotherapy has been used
with little success in disseminated thyroid cancer.
– Adriamycin and Taxol are the most frequently used agents.
Medullary Carcinoma
• MTCs account for about 5% of thyroid malignancies
• arise from the parafollicular or C cells of the
thyroid, which, in turn, are derived from the
ultimobranchial bodies.
• These cells are concentrated superolaterally in the
thyroid lobes, which is where MTC usually develops.
• C cells secrete calcitonin, a 32-amino-acid polypeptide
that functions to lower serum calcium levels. (regulator
of calcium metabolism)
• Most MTCs occur sporadically.
• However, approximately 25% occur within the
spectrum of several inherited syndromes such as
familial medullary thyroid cancer, MEN2A, and MEN2B.
– All these variants are known to result secondary to
germline mutations in the RET proto-oncogene.
• Patients with MTC often present with a neck mass that may be
associated with palpable cervical lymphadenopathy (15 to 20%).
• Local pain or aching is more common in patients with these tumors,
and local invasion may produce symptoms of dysphagia, dyspnea,
or dysphonia.
• Distant blood-borne metastases to the liver, bone (frequently
osteoblastic), and lung occur later in the disease.
• The female:male ratio is 1.5:1.
• Most patients present between 50 and 60 years of age, although
patients with familial disease present at a younger age.
• Medullary thyroid tumors secrete
– not only calcitonin and carcinoembryonic antigen (CEA),
– but also other peptides such as calcitonin gene-related peptide
(CGRP), histaminadases, prostaglandins E2 and F2, and serotonin.
Pathology
• MTCs are typically unilateral (80%) in patients
with sporadic disease,
• and multicentric in familial cases, with
bilateral tumors occurring in up to 90% of
familial patients.
• Familial cases are also associated with C-cell
hyperplasia, which is considered a
premalignant lesion
Diagnosis
• The diagnosis of MTC is established
– by history, physical examination,
– raised serum calcitonin or CEA levels,
– FNA cytology of the thyroid mass.

• Attention to family history is important
• because approximately 25% of patients with
MTC have familial disease.
• Total thyroidectomy is the treatment of choice
for patients with MTC because of
– the high incidence of multicentricity,
– the more aggressive course,
– 131I therapy is not usually effective.

• External beam radiotherapy is controversial,
but is recommended for patients with
unresectable residual or recurrent tumor.
• There is no effective chemotherapy regimen.
Anaplastic Carcinoma
• approximately 1% of all thyroid malignancies
• Women are more commonly affected, and the
majority of tumors present in the seventh and
eighth decades of life.
• The typical patient has a long-standing neck
mass, which rapidly enlarges and may be painful.
• Associated symptoms, such as dysphonia,
dysphagia, and dyspnea, are common.
• The tumor is large and may be fixed to
surrounding structures or may be ulcerated
• Lymph nodes usually are palpable at
presentation.
• Evidence of metastatic spread also may be
present.
• Diagnosis is confirmed by FNA biopsy revealing
characteristic giant and multinucleated cells.
• Incisional biopsy is occasionally needed to
confirm the diagnosis and isthmusectomy is
performed to alleviate tracheal compression.
• Pathology
– Gross - firm and whitish in appearance.
– Microscopically, sheets of cells with marked
heterogeneity are seen.

• Treatment and Prognosis
– This tumor is one of the most aggressive thyroid
malignancies, with few patients surviving 6
months beyond diagnosis.
– All forms of treatment have been disappointing.
Lymphoma
• A ccount for less than 1% of thyroid malignancies
• most are of the non-Hodgkin's B-cell type.
• Although the disease can arise as part of a generalized
lymphomatous condition, most thyroid lymphomas develop
in patients with chronic lymphocytic thyroiditis.
• Patients usually present with symptoms similar to those of
patients with anaplastic carcinoma, although the rapidly
enlarging neck mass often is painless.
• Patients may present with acute respiratory distress.
• The diagnosis usually is suggested by FNA biopsy, although
needle-core or open biopsy may be necessary for definitive
diagnosis.
• Staging studies should be obtained to assess the extent of
extrathyroidal spread.
Treatment and Prognosis
• Respond rapidly to chemotherapy (CHOP—cyclophosphamide,
doxorubicin, vincristine, and prednisone), which is also associated
with improved survival.
• Combined treatment with radiotherapy and chemotherapy is often
recommended.
• Thyroidectomy and nodal resection are used to alleviate symptoms
of airway obstruction in patients who do not respond quickly to the
above regimens, or in patients who have completed the regimen
prior to diagnosis.
• Prognosis depends on
– the histologic grade of the tumor and
– whether the lymphoma is confined to the thyroid gland or is
disseminated.

• The overall 5-year survival rate is about 50%;
– patients with extrathyroidal disease have markedly lower survival
rates.
Metastatic Carcinoma
• The thyroid gland is a rare site of metastases from
other cancers, including kidney, breast, lung, and
melanoma.
• Clinical examination and a review of the patient's
history often suggest the source of the metastatic
disease, and FNA biopsy usually provides
definitive diagnosis.
• Resection of the thyroid, usually lobectomy, may
be helpful in many patients, depending on the
status of their primary tumor

Weitere ähnliche Inhalte

Was ist angesagt?

Differentiated thyroid carcinoma
Differentiated thyroid carcinomaDifferentiated thyroid carcinoma
Differentiated thyroid carcinomaARIJIT8891
 
Undifferentiated thyroid carcinoma
Undifferentiated thyroid carcinomaUndifferentiated thyroid carcinoma
Undifferentiated thyroid carcinomaHassn Aljubory
 
Seminar on Cancer of Thyroid gland
Seminar on Cancer of Thyroid glandSeminar on Cancer of Thyroid gland
Seminar on Cancer of Thyroid glandYousuf Choudhury
 
Carcinoma Thyroid presentation
Carcinoma Thyroid presentation Carcinoma Thyroid presentation
Carcinoma Thyroid presentation Abhinav Mutneja
 
Bethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyBethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyariva zhagan
 
Thyroid carcinoma
Thyroid carcinomaThyroid carcinoma
Thyroid carcinomaSumer Yadav
 
Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary Himanshu Soni
 
Papillary thyroid carcinoma
Papillary thyroid carcinomaPapillary thyroid carcinoma
Papillary thyroid carcinomanadiagulnaz
 
Histopathological dignosis of carcinoma of breast
Histopathological dignosis of carcinoma of breastHistopathological dignosis of carcinoma of breast
Histopathological dignosis of carcinoma of breastNazia Ashraf
 
Papillary and follicular thyroid cancer
Papillary and follicular thyroid cancerPapillary and follicular thyroid cancer
Papillary and follicular thyroid cancerikramdr01
 

Was ist angesagt? (20)

THYROID MALIGNANCIES
THYROID MALIGNANCIESTHYROID MALIGNANCIES
THYROID MALIGNANCIES
 
Differentiated thyroid carcinoma
Differentiated thyroid carcinomaDifferentiated thyroid carcinoma
Differentiated thyroid carcinoma
 
Thyroid ca
Thyroid caThyroid ca
Thyroid ca
 
Undifferentiated thyroid carcinoma
Undifferentiated thyroid carcinomaUndifferentiated thyroid carcinoma
Undifferentiated thyroid carcinoma
 
Seminar on Cancer of Thyroid gland
Seminar on Cancer of Thyroid glandSeminar on Cancer of Thyroid gland
Seminar on Cancer of Thyroid gland
 
Thyroid Tumors
Thyroid TumorsThyroid Tumors
Thyroid Tumors
 
Thyroid ca
Thyroid caThyroid ca
Thyroid ca
 
Thyroid Cancer
Thyroid CancerThyroid Cancer
Thyroid Cancer
 
Carcinoma Thyroid presentation
Carcinoma Thyroid presentation Carcinoma Thyroid presentation
Carcinoma Thyroid presentation
 
Thyroid malignancies
Thyroid malignanciesThyroid malignancies
Thyroid malignancies
 
Bethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyBethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytology
 
Thyroid carcinoma
Thyroid carcinomaThyroid carcinoma
Thyroid carcinoma
 
Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary
 
Papillary thyroid carcinoma
Papillary thyroid carcinomaPapillary thyroid carcinoma
Papillary thyroid carcinoma
 
Histopathological dignosis of carcinoma of breast
Histopathological dignosis of carcinoma of breastHistopathological dignosis of carcinoma of breast
Histopathological dignosis of carcinoma of breast
 
Thyroid Cancer
Thyroid CancerThyroid Cancer
Thyroid Cancer
 
Papillary and follicular thyroid cancer
Papillary and follicular thyroid cancerPapillary and follicular thyroid cancer
Papillary and follicular thyroid cancer
 
Ca thyroid
Ca thyroidCa thyroid
Ca thyroid
 
Thyroid neoplasms
Thyroid neoplasmsThyroid neoplasms
Thyroid neoplasms
 
Ca oropharynx
Ca oropharynxCa oropharynx
Ca oropharynx
 

Andere mochten auch

Neoplasms of the thyroid
Neoplasms of the thyroidNeoplasms of the thyroid
Neoplasms of the thyroidKwadwo Abu
 
Thyroid cancer ppt
Thyroid cancer ppt Thyroid cancer ppt
Thyroid cancer ppt pendom11
 
Molecular basis of thyroid neoplasm subhasish
Molecular basis of thyroid neoplasm  subhasishMolecular basis of thyroid neoplasm  subhasish
Molecular basis of thyroid neoplasm subhasishSubhasish Saha
 
Blood components and recent advances
Blood components and recent advancesBlood components and recent advances
Blood components and recent advancesAnkita Das
 
Lect 2-pitutary tumor(1)
Lect 2-pitutary tumor(1)Lect 2-pitutary tumor(1)
Lect 2-pitutary tumor(1)Mohanad Mohanad
 
An introduction to thyroid neoplasms
An introduction to thyroid neoplasmsAn introduction to thyroid neoplasms
An introduction to thyroid neoplasmshosam hamza
 
Rehab cervical through cocegeal power pt
Rehab cervical through cocegeal power ptRehab cervical through cocegeal power pt
Rehab cervical through cocegeal power ptMeklelle university
 
Differentiated thyroid carcinoma
Differentiated thyroid    carcinomaDifferentiated thyroid    carcinoma
Differentiated thyroid carcinomaAngel Das
 
Surg path thyroid.special
Surg path thyroid.specialSurg path thyroid.special
Surg path thyroid.specialspecialclass
 
SURGERY OF THE THYROID
SURGERY OF THE THYROIDSURGERY OF THE THYROID
SURGERY OF THE THYROIDshabeel pn
 
Tumors of the endocrine system
Tumors of the endocrine systemTumors of the endocrine system
Tumors of the endocrine systemDr./ Ihab Samy
 
Neoplasms of thyroid gland
Neoplasms of thyroid glandNeoplasms of thyroid gland
Neoplasms of thyroid glandMohit kadyan
 
Thyroid parathyroid kinara
Thyroid parathyroid kinaraThyroid parathyroid kinara
Thyroid parathyroid kinaraKinara Kenyoru
 
Multiple endocrine neoplasia syndromes 1
Multiple endocrine neoplasia syndromes 1Multiple endocrine neoplasia syndromes 1
Multiple endocrine neoplasia syndromes 1Sajad Al-Ramahy
 
Diseases of endocrinal glands
Diseases of endocrinal glandsDiseases of endocrinal glands
Diseases of endocrinal glandsraj kumar
 
Thyroid surgery and neoplasms of thyroid
Thyroid surgery and neoplasms of thyroidThyroid surgery and neoplasms of thyroid
Thyroid surgery and neoplasms of thyroidFaryal Mangrio
 

Andere mochten auch (20)

Neoplasms of the thyroid
Neoplasms of the thyroidNeoplasms of the thyroid
Neoplasms of the thyroid
 
Thyroid neoplasms
Thyroid neoplasmsThyroid neoplasms
Thyroid neoplasms
 
Thyroid cancer ppt
Thyroid cancer ppt Thyroid cancer ppt
Thyroid cancer ppt
 
Molecular basis of thyroid neoplasm subhasish
Molecular basis of thyroid neoplasm  subhasishMolecular basis of thyroid neoplasm  subhasish
Molecular basis of thyroid neoplasm subhasish
 
Thyroid Tumor
Thyroid TumorThyroid Tumor
Thyroid Tumor
 
Blood components and recent advances
Blood components and recent advancesBlood components and recent advances
Blood components and recent advances
 
Lect 2-pitutary tumor(1)
Lect 2-pitutary tumor(1)Lect 2-pitutary tumor(1)
Lect 2-pitutary tumor(1)
 
The Endocrine System
The Endocrine SystemThe Endocrine System
The Endocrine System
 
An introduction to thyroid neoplasms
An introduction to thyroid neoplasmsAn introduction to thyroid neoplasms
An introduction to thyroid neoplasms
 
Rehab cervical through cocegeal power pt
Rehab cervical through cocegeal power ptRehab cervical through cocegeal power pt
Rehab cervical through cocegeal power pt
 
Differentiated thyroid carcinoma
Differentiated thyroid    carcinomaDifferentiated thyroid    carcinoma
Differentiated thyroid carcinoma
 
Surg path thyroid.special
Surg path thyroid.specialSurg path thyroid.special
Surg path thyroid.special
 
SURGERY OF THE THYROID
SURGERY OF THE THYROIDSURGERY OF THE THYROID
SURGERY OF THE THYROID
 
Tumors of the endocrine system
Tumors of the endocrine systemTumors of the endocrine system
Tumors of the endocrine system
 
Neoplasms of thyroid gland
Neoplasms of thyroid glandNeoplasms of thyroid gland
Neoplasms of thyroid gland
 
Patho Endocrine
Patho   EndocrinePatho   Endocrine
Patho Endocrine
 
Thyroid parathyroid kinara
Thyroid parathyroid kinaraThyroid parathyroid kinara
Thyroid parathyroid kinara
 
Multiple endocrine neoplasia syndromes 1
Multiple endocrine neoplasia syndromes 1Multiple endocrine neoplasia syndromes 1
Multiple endocrine neoplasia syndromes 1
 
Diseases of endocrinal glands
Diseases of endocrinal glandsDiseases of endocrinal glands
Diseases of endocrinal glands
 
Thyroid surgery and neoplasms of thyroid
Thyroid surgery and neoplasms of thyroidThyroid surgery and neoplasms of thyroid
Thyroid surgery and neoplasms of thyroid
 

Ähnlich wie Thyroid neoplasms

Differentiated thyroid carcinoma
Differentiated thyroid carcinomaDifferentiated thyroid carcinoma
Differentiated thyroid carcinomaAnkur Kajal
 
Solitary thyroid nodule
Solitary thyroid nodule Solitary thyroid nodule
Solitary thyroid nodule Jaydeep Malakar
 
Solitary thyroid nodule
Solitary   thyroid noduleSolitary   thyroid nodule
Solitary thyroid noduleDukhum Magu
 
thyroid nodules and cancer.pptx
thyroid nodules and cancer.pptxthyroid nodules and cancer.pptx
thyroid nodules and cancer.pptxLara Masri
 
thyroid malignancy
thyroid malignancy thyroid malignancy
thyroid malignancy Abdul Waris
 
Thyroid cancers
Thyroid cancersThyroid cancers
Thyroid cancerslalith39
 
Prostate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology stagingProstate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology stagingOSBORNMIKE
 
Cytohistological Correlation Of Malignant Thyroid Lesions
Cytohistological Correlation Of Malignant Thyroid LesionsCytohistological Correlation Of Malignant Thyroid Lesions
Cytohistological Correlation Of Malignant Thyroid LesionsDr.Pooja Dwivedi
 
Clinical approach to solitary pulmonary nodule final
Clinical approach to solitary pulmonary nodule finalClinical approach to solitary pulmonary nodule final
Clinical approach to solitary pulmonary nodule finalShivaom Chaurasia
 
Neuroblastoma & Wilms tumor.pptx
Neuroblastoma & Wilms tumor.pptxNeuroblastoma & Wilms tumor.pptx
Neuroblastoma & Wilms tumor.pptxIrfanNashad1
 
ca uterus cancer in uterus, common female problem
ca uterus cancer in uterus, common female problemca uterus cancer in uterus, common female problem
ca uterus cancer in uterus, common female problemSasiSoman3
 
Malignant lung tumours
Malignant lung tumoursMalignant lung tumours
Malignant lung tumoursfarranajwa
 

Ähnlich wie Thyroid neoplasms (20)

Thyroid neoplasms
Thyroid neoplasmsThyroid neoplasms
Thyroid neoplasms
 
Thyroid Malignancies
Thyroid MalignanciesThyroid Malignancies
Thyroid Malignancies
 
Differentiated thyroid carcinoma
Differentiated thyroid carcinomaDifferentiated thyroid carcinoma
Differentiated thyroid carcinoma
 
Solitary thyroid nodule
Solitary thyroid nodule Solitary thyroid nodule
Solitary thyroid nodule
 
Approach to thyroid cancer
Approach to thyroid cancerApproach to thyroid cancer
Approach to thyroid cancer
 
Solitary thyroid nodule
Solitary   thyroid noduleSolitary   thyroid nodule
Solitary thyroid nodule
 
thyroid nodules and cancer.pptx
thyroid nodules and cancer.pptxthyroid nodules and cancer.pptx
thyroid nodules and cancer.pptx
 
Thyroid-Nodules-Cancers.pptx
Thyroid-Nodules-Cancers.pptxThyroid-Nodules-Cancers.pptx
Thyroid-Nodules-Cancers.pptx
 
thyroid malignancy
thyroid malignancy thyroid malignancy
thyroid malignancy
 
Cystic neoplasm of pancrease dr mnr
Cystic neoplasm of pancrease dr mnrCystic neoplasm of pancrease dr mnr
Cystic neoplasm of pancrease dr mnr
 
ca_thyroid.ppt
ca_thyroid.pptca_thyroid.ppt
ca_thyroid.ppt
 
thyroid cancer
thyroid cancerthyroid cancer
thyroid cancer
 
Thyroid cancers
Thyroid cancersThyroid cancers
Thyroid cancers
 
Prostate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology stagingProstate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology staging
 
Cytohistological Correlation Of Malignant Thyroid Lesions
Cytohistological Correlation Of Malignant Thyroid LesionsCytohistological Correlation Of Malignant Thyroid Lesions
Cytohistological Correlation Of Malignant Thyroid Lesions
 
Clinical approach to solitary pulmonary nodule final
Clinical approach to solitary pulmonary nodule finalClinical approach to solitary pulmonary nodule final
Clinical approach to solitary pulmonary nodule final
 
Anal canal cancer
Anal canal cancerAnal canal cancer
Anal canal cancer
 
Neuroblastoma & Wilms tumor.pptx
Neuroblastoma & Wilms tumor.pptxNeuroblastoma & Wilms tumor.pptx
Neuroblastoma & Wilms tumor.pptx
 
ca uterus cancer in uterus, common female problem
ca uterus cancer in uterus, common female problemca uterus cancer in uterus, common female problem
ca uterus cancer in uterus, common female problem
 
Malignant lung tumours
Malignant lung tumoursMalignant lung tumours
Malignant lung tumours
 

Mehr von Meklelle university (20)

Chronic obstructive pulmonary disease ppt
Chronic obstructive pulmonary disease   pptChronic obstructive pulmonary disease   ppt
Chronic obstructive pulmonary disease ppt
 
Acute urinary retention mgt
Acute urinary retention mgtAcute urinary retention mgt
Acute urinary retention mgt
 
Lung ca
Lung caLung ca
Lung ca
 
Head injury (2)
Head injury (2)Head injury (2)
Head injury (2)
 
6 gall blader & biliary tree diseases
6 gall blader & biliary tree diseases6 gall blader & biliary tree diseases
6 gall blader & biliary tree diseases
 
Dermatitis and eczema
Dermatitis and eczemaDermatitis and eczema
Dermatitis and eczema
 
Rehab of injuries to the wrist and hand power pt
Rehab of  injuries to the wrist and hand power ptRehab of  injuries to the wrist and hand power pt
Rehab of injuries to the wrist and hand power pt
 
Rehab abdomen and thorax power pt
Rehab abdomen and thorax power ptRehab abdomen and thorax power pt
Rehab abdomen and thorax power pt
 
Chapter 9 power pt
Chapter 9  power ptChapter 9  power pt
Chapter 9 power pt
 
INTRODUCTION TO BIO STATISTICS
INTRODUCTION TO BIO STATISTICS INTRODUCTION TO BIO STATISTICS
INTRODUCTION TO BIO STATISTICS
 
Research methodology by hw
 Research methodology by hw Research methodology by hw
Research methodology by hw
 
Prom
PromProm
Prom
 
Goiter
GoiterGoiter
Goiter
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Breast ca
Breast  ca Breast  ca
Breast ca
 
Prenatal diagnosis
Prenatal diagnosisPrenatal diagnosis
Prenatal diagnosis
 
Minor conditions of pregnancy
Minor conditions of pregnancyMinor conditions of pregnancy
Minor conditions of pregnancy
 
Antenatal care
Antenatal careAntenatal care
Antenatal care
 
Menestrual cycle, fertilization & implantation
Menestrual cycle, fertilization & implantationMenestrual cycle, fertilization & implantation
Menestrual cycle, fertilization & implantation
 
Induction OF labor
Induction OF laborInduction OF labor
Induction OF labor
 

Kürzlich hochgeladen

Introduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptx
Introduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptxIntroduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptx
Introduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptxspmdoc
 
Overview of nervous system,mental health
Overview of nervous system,mental healthOverview of nervous system,mental health
Overview of nervous system,mental healthvelveenamaran
 
maternal child health care.pptx community health nursing in determinants of h...
maternal child health care.pptx community health nursing in determinants of h...maternal child health care.pptx community health nursing in determinants of h...
maternal child health care.pptx community health nursing in determinants of h... M.Josephin Dayana
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxLikeways
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
CONGENITAL HYPOTHYROIDISM.pptxin neonates
CONGENITAL HYPOTHYROIDISM.pptxin neonatesCONGENITAL HYPOTHYROIDISM.pptxin neonates
CONGENITAL HYPOTHYROIDISM.pptxin neonatesShubhendra4
 
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxEICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxRajendra Dev Bhatt
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
nuclear medicine 3 marks questions and answers.pdf
nuclear medicine 3 marks questions and answers.pdfnuclear medicine 3 marks questions and answers.pdf
nuclear medicine 3 marks questions and answers.pdfGanesan Yogananthem
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Pregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfPregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfMedicoseAcademics
 
Dental Digital Scanners: Intraoral and Extraoral 3D Scanners
Dental Digital Scanners: Intraoral and Extraoral 3D ScannersDental Digital Scanners: Intraoral and Extraoral 3D Scanners
Dental Digital Scanners: Intraoral and Extraoral 3D Scannersassem awad
 
1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf
1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf
1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdfKs doctor
 
Antiperspants & Deodrants.pptx Cosmetic science
Antiperspants & Deodrants.pptx Cosmetic scienceAntiperspants & Deodrants.pptx Cosmetic science
Antiperspants & Deodrants.pptx Cosmetic scienceShital Khade sabale
 
Staying Safe in Hospitals Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals Fire Safety Guidelines for Hospitals in IndiaStaying Safe in Hospitals Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals Fire Safety Guidelines for Hospitals in IndiaBasic Elements
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Histology of Nervous System II - Peripheral Nervous System.pdf
Histology of Nervous System II - Peripheral Nervous System.pdfHistology of Nervous System II - Peripheral Nervous System.pdf
Histology of Nervous System II - Peripheral Nervous System.pdfMedicoseAcademics
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
CESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTION
CESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTIONCESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTION
CESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTIONNGODINH4
 

Kürzlich hochgeladen (20)

Introduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptx
Introduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptxIntroduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptx
Introduction-to-Host-Defenses-in-Infectious-Disease-Epidemiology.pptx
 
Overview of nervous system,mental health
Overview of nervous system,mental healthOverview of nervous system,mental health
Overview of nervous system,mental health
 
maternal child health care.pptx community health nursing in determinants of h...
maternal child health care.pptx community health nursing in determinants of h...maternal child health care.pptx community health nursing in determinants of h...
maternal child health care.pptx community health nursing in determinants of h...
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
CONGENITAL HYPOTHYROIDISM.pptxin neonates
CONGENITAL HYPOTHYROIDISM.pptxin neonatesCONGENITAL HYPOTHYROIDISM.pptxin neonates
CONGENITAL HYPOTHYROIDISM.pptxin neonates
 
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxEICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
nuclear medicine 3 marks questions and answers.pdf
nuclear medicine 3 marks questions and answers.pdfnuclear medicine 3 marks questions and answers.pdf
nuclear medicine 3 marks questions and answers.pdf
 
Conversations With Peers About T2DM: Best Practices for Optimizing Treatment ...
Conversations With Peers About T2DM: Best Practices for Optimizing Treatment ...Conversations With Peers About T2DM: Best Practices for Optimizing Treatment ...
Conversations With Peers About T2DM: Best Practices for Optimizing Treatment ...
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Pregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdfPregnacny, Parturition, and Lactation.pdf
Pregnacny, Parturition, and Lactation.pdf
 
Dental Digital Scanners: Intraoral and Extraoral 3D Scanners
Dental Digital Scanners: Intraoral and Extraoral 3D ScannersDental Digital Scanners: Intraoral and Extraoral 3D Scanners
Dental Digital Scanners: Intraoral and Extraoral 3D Scanners
 
1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf
1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf
1130329-高雄地區第496次小兒科聯合病例討論會-高雄市立聯合醫院.pdf
 
Antiperspants & Deodrants.pptx Cosmetic science
Antiperspants & Deodrants.pptx Cosmetic scienceAntiperspants & Deodrants.pptx Cosmetic science
Antiperspants & Deodrants.pptx Cosmetic science
 
Staying Safe in Hospitals Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals Fire Safety Guidelines for Hospitals in IndiaStaying Safe in Hospitals Fire Safety Guidelines for Hospitals in India
Staying Safe in Hospitals Fire Safety Guidelines for Hospitals in India
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Histology of Nervous System II - Peripheral Nervous System.pdf
Histology of Nervous System II - Peripheral Nervous System.pdfHistology of Nervous System II - Peripheral Nervous System.pdf
Histology of Nervous System II - Peripheral Nervous System.pdf
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
CESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTION
CESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTIONCESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTION
CESAREAN DELIVERY AND VAGINAL DELIVERY AFTER CAESAREAN SECTION
 

Thyroid neoplasms

  • 2. Solitary Thyroid Nodule • The majority of thyroid nodules are benign and do not require removal. • Therefore, it is of utmost importance to determine which patients with solitary thyroid nodule would benefit from surgery.
  • 3. History • Details regarding the nodule, such as – time of onset, change in size, • Associated symptoms, such as – pain, dysphagia, dyspnea, or choking, should be elicited. • Pain is an unusual symptom and when present, should raise suspicion for – intrathyroidal hemorrhage in a benign nodule, thyroiditis, or malignancy. • Patients with medullary thyroid cancer may complain of a dull, aching sensation.
  • 4. History • A hx of hoarseness is worrisome because it may be secondary to malignant involvement of the recurrent laryngeal nerves. • Most importantly, patients should be questioned regarding risk factors for malignancy, – such as exposure to ionizing radiation and family history of thyroid and other malignancies associated with thyroid cancer. • External Beam Radiation- The risk is maximum 20 to 30 years after exposure
  • 5. • Family History – is a risk factor for the development of both medullary and nonmedullary thyroid cancer – Familial medullary thyroid cancers occur in isolation or in association with other tumors as part of multiple endocrine neoplasia type 2 (MEN2) syndromes. – Nonmedullary thyroid cancers can occur in association with other known familial cancer syndromes such as • Cowden's syndrome, Werner's (adult progeroid) syndrome, and familial adenomatous polyposis. – Nonmedullary thyroid cancers also can occur independently of these syndromes.
  • 6. Physical Examination • Thyroid masses move with swallowing and failure to observe the patient swallowing may lead one to miss a large substernal goiter. • The thyroid gland is best palpated from behind the patient and with the neck in mild extension. • The cricoid cartilage is an important landmark – because the isthmus is situated just below it. • Nodules that are hard, gritty, or fixed to surrounding structures, such as to the trachea or strap muscles – more likely to be malignant. • The cervical chain of lymph nodes should be assessed as well as the nodes in the posterior triangle. • One should examine the patient for a Delphian node and pyramidal lobe situated just above the thyroid isthmus and cricoid cartilage.
  • 8. Diagnostic Tests • Fine-Needle Aspiration Biopsy – single most important test in the evaluation of patients with thyroid masses – can be performed with or without ultrasound guidance. – Ultrasound guidance is recommended for • nodules that are difficult to palpate and • for complex, solid cystic nodules that recur after the initial aspiration. • After FNA biopsy, the majority of nodules can be categorized into the following groups: benign (65%), suspicious (20%), malignant (5%), and nondiagnostic (10%). • The incidence of false-positive results is approximately 1% and false-negative results occur in approximately 3% of patients.
  • 9. • Nondiagnostic, it should usually be repeated. – Bloody FNA biopsy may also be reported as nondiagnostic and often indicates a follicular neoplasm. • Benign lesions include cysts and colloid nodules. The risk of malignancy in this setting is less than 3%. • Suspicious cytology- The risk of malignancy is 10 to 20%. – Most are follicular or Hürthle cell neoplasms. – Diagnosis of malignancy in this situation relies on demonstrating capsular or vascular invasion, • features that cannot be determined via FNA biopsy.
  • 10. • FNA biopsy is also less reliable in patients who have a history of head and neck irradiation or a family history of thyroid cancer, – because of a higher likelihood of multifocal lesions. • There is little or no value in repeating an FNA biopsy for a follicular or Hürthle cell lesion, • Repeat FNA biopsy can be useful for patients when the cytology has some abnormalities that suggest a papillary thyroid cancer, but not enough to make this diagnosis.
  • 11. Laboratory Studies • Serum TSH- Most patients with thyroid nodules are euthyroid. – If a patient with a nodule is found to be hyperthyroid, the risk of malignancy is approximately 1%. • Serum Tg levels cannot differentiate benign from malignant thyroid nodules unless the levels are extremely high, – in which case metastatic thyroid cancer should be suspected. – Useful in following patients who have undergone total thyroidectomy for thyroid cancer – For serial evaluation of patients undergoing nonoperative management of thyroid nodules. • Serum calcitonin levels should be obtained in patients with medullary thyroid cancer or a family history of medullary thyroid cancer (MTC) or MEN2.
  • 12. Imaging • Ultrasound is helpful for detecting nonpalpable thyroid nodules, – for differentiating solid from cystic nodules, and – for identifying adjacent lymphadenopathy. – It also provides a noninvasive and inexpensive method of following the size of suspected benign nodules diagnosed by FNA biopsy. • CT and MRI are unnecessary in the routine evaluation of thyroid tumors, except for large, fixed, or substernal lesions. • Scanning the thyroid with 123I or 99mTc is rarely necessary, unless evaluating patients for "hot" or autonomous thyroid nodules. – currently recommended in the assessment of thyroid nodules only in patients – who have follicular thyroid nodules on FNA biopsy and a suppressed TSH.
  • 13. Management • Malignant tumors are treated by thyroidectomy • Simple thyroid cysts resolve with aspiration in approximately 75% of cases, although some require a second or third aspiration. – Unilateral thyroid lobectomy is recommended • If the cyst persists after three attempts at aspiration. • for cysts greater than 4 cm in diameter • for complex cysts with solid and cystic components, because of higher incidence of malignancy (15%). • When FNA biopsy is used in complex nodules, the solid portion should be sampled.
  • 14. • If a colloid nodule is diagnosed by FNA biopsy, patients should still be observed with serial ultrasound and Tg measurements. – If the nodule enlarges, repeat FNA biopsy is often indicated. – l-thyroxine in doses sufficient to maintain a serum TSH level between 0.1 and 1.0 µU/ mL may also be administered. • Most effective for nodules smaller than 3 cm. – Previous irradiation of the thyroid gland or who has a family history of thyroid cancer• total or near-total thyroidectomy – High incidence of thyroid cancer (40%) – and decreased reliability of FNA biopsy in this setting.
  • 15. Papillary Carcinoma • 80% of all thyroid malignancies in iodine-sufficient areas • The predominant thyroid cancer in children and individuals exposed to external radiation. • Occurs more often in women, with a 2:1 female: male ratio; • The mean age at presentation is 30 to 40 years. • Most patients are euthyroid and present with a slowgrowing painless mass in the neck. • Dysphagia, dyspnea, and dysphonia are usually associated with locally advanced invasive disease. • Lymph node metastases are common, especially in children and young adults, and may be the presenting complaint.
  • 16. • The so-called "lateral aberrant thyroid" almost always denotes a cervical lymph node that has been invaded by metastatic cancer. • Suspicion of thyroid cancer often originates through physical examination of the patient and a review of the patient's history. • Diagnosis is established by FNA biopsy of the thyroid mass or lymph node. • Distant metastases are uncommon at initial presentation, but may ultimately develop in up to 20% of patients. • The most common sites are the lungs, followed by bone, liver, and brain.
  • 17. Pathology • Gross - hard and whitish and remain flat on sectioning with a blade, in contrast to normal tissue or benign nodular lesions that tend to bulge. – Macroscopic calcification, necrosis, or cystic change may be apparent. • Histologically- may exhibit papillary projections, a mixed pattern of papillary and follicular structures, or a pure follicular pattern (follicular variant). • The diagnosis is established by characteristic cellular features. – Cells are cuboidal with pale, abundant cytoplasm, – "grooving," crowded nuclei, and intranuclear cytoplasmic inclusions, leading to the designation of Orphan Annie nuclei, which allows diagnosis by FNA biopsy. – Psammoma bodies, which are microscopic, calcified deposits representing clumps of sloughed cells, may be present.
  • 18. • Mixed papillary–follicular tumors and follicular variant of papillary carcinoma are classified as papillary carcinomas because they act biologically as papillary carcinomas. • Multifocality - in up to 85% of cases. It is associated with an increased risk of cervical nodal metastases • Rarely invade adjacent structures such as the trachea, esophagus, and recurrent laryngeal nerves. • Other variants of papillary carcinoma (approximately 1% of all papillary carcinomas) include – tall cell, insular, columnar, diffuse sclerosing, clear cell, trabecular, and poorly differentiated types. – They are generally associated with a worse prognosis
  • 19. Prognostic Indicators • In general, patients with PTC have an excellent prognosis with a greater than 95% 10-year survival rate. • AGES scoring system, which incorporates age, histologic grade, extrathyroidal invasion and metastases, and tumor size to predict the risk of dying from papillary cancer. • The MACIS scale- metastases, age at presentation, completeness of original surgical resection, extrathyroidal invasion, and size of original lesion • AMES system
  • 20. Papillary or Follicular Tumors Stage Younger than age 45 Years I II Age 45 Years and older I II III IVA IVB IVC Medullary Thyroid Cancer Stage I II III IVA IVB IVC Anaplastic Cancer Stage IVA IVB IVC TNM Any T, Any N, M0 Any T, Any N, M1 T1, N0, M0 T2, N0, M0 T3, N0, M0; T1-3, N1a, M0 T4a, N0-1a, M0; T1-4a, N1b, M0 T4b, Any N, M0 Any T, any N, M1 TNM T1, N0, M0 T2-3, N0, M0 T1-3, N1a, M0 T4a, N0-1a, M0; T1-4a, N1b, M0 T4b, any N, M0 Any T, Any N, M1 TNM T4a, Any N, M0 T4b, Any N, M0 Any T, Any M, M1
  • 21. Definitions • • • • • • Primary tumor (T) TX = Primary tumor cannot be assessed T0 = No evidence of primary tumor T1 = Tumor ≤2 cm in diameter, limited to thyroid T2 = Tumor >2 cm but <4 cm in diameter, limited to thyroid T3 = Tumor >4 cm in diameter, limited to thyroid, or any tumor with minimal extrathyroidal invasion • T4a = Any size tumor extending beyond capsule to invade subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve, or intrathyroidal anaplastic cancer • T4b = Tumor invading prevertebral fascia, or encasing carotid artery or mediastinal vessels; or extrathyroidal anaplastic cancer
  • 22. • Regional lymph nodes (N)—include central, lateral cervical, and upper mediastinal nodes • NX = Regional lymph nodes cannot be assessed • N0 = No regional lymph node metastasis • N1 = Regional lymph node metastasis • N1a = Metastases to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) • N1b = Metastases to unilateral, bilateral, or contralateral cervical or superior mediastinal LNs
  • 23. Surgical Treatment • Total or near-total thyroidectomy
  • 24. Follicular Carcinoma • Follicular carcinomas account for 10% of thyroid cancers • Occur more commonly in iodine-deficient areas. • The overall incidence of this tumor is, probably as a result of iodine supplementation and improved histologic classification. • female: male ratio of 3:1, • a mean age at presentation of 50 years.
  • 25. • Usually present as solitary thyroid nodules, – Occasionally with a history of rapid size increase, and long-standing goiter. • Pain is uncommon, unless hemorrhage into the nodule has occurred. • Unlike papillary cancers, cervical lymphadenopathy is uncommon at initial presentation (approximately 5%) • Although distant metastases may be present.
  • 26. • may be hyperfunctioning in less than 1% of cases, – leading patients to present with signs and symptoms of thyrotoxicosis. • FNA biopsy is unable to distinguish benign follicular lesions from follicular carcinomas. • Therefore, preoperative diagnosis of cancer is difficult unless distant metastases are present. • Large follicular tumors (>4 cm) in older men are more likely to be malignant.
  • 27. Pathology • Usually solitary lesions, the majority of which are surrounded by a capsule. • Histologically, follicles are present, but the lumen may be devoid of colloid. • Malignancy is defined by the presence of capsular and vascular invasion. • Minimally-invasive tumors – appear grossly encapsulated – but have evidence of microscopic invasion through the tumor capsule and/or – invasion into small- to medium-size vessels (venous caliber) in or immediately outside the capsule, but not within the tumor.
  • 28. • Widely invasive tumors demonstrate evidence of large-vessel invasion and/or broad areas of tumor invasion through the capsule. – They may, in fact, be unencapsulated. • Tumor infiltration and invasion, as well as tumor thrombus within the middle thyroid or jugular veins, may be apparent at operation.
  • 29. Surgical Treatment and Prognosis • Patients diagnosed by FNA biopsy as having a follicular lesion should undergo thyroid lobectomy because at least 80% of these patients will have benign adenomas. • Some surgeons recommend total thyroidectomy in older patients with follicular lesions larger than 4 cm because of the higher risk of cancer in this setting (50%). • Intraoperative frozen-section examination – usually is not helpful, – but should be performed • when there is evidence of capsular or vascular invasion, or • when adjacent lymphadenopathy is present. • Total thyroidectomy should be performed when thyroid cancer is diagnosed.
  • 30. Hürthle Cell Carcinoma • 3% of all thyroid malignancies • Subtype of follicular thyroid cancer. • Like follicular cancers, Hürthle cell cancers are characterized by vascular or capsular invasion, and therefore cannot be diagnosed by FNA biopsy. • Tumors contain sheets of eosinophilic cells packed with mitochondria, which are derived from the oxyphilic cells of the thyroid gland. • differ from follicular carcinomas in that they are more often – multifocal and bilateral (approximately 30%), – usually do not take up RAI (approximately 5%), – are more likely to metastasize to local nodes (25%) and distant sites – are associated with a higher mortality rate (20% at 10 yrs).
  • 31. • Hence, they are considered to be a separate class of tumors by some surgeons. • Management is similar to that of follicular neoplasms, – with lobectomy and isthmusectomy being sufficient surgical treatment for unilateral Hürthle cell adenomas. • When Hürthle cell neoplasms are found to be invasive on intraoperative, frozen-section, or definitive paraffin-section histology, – then total thyroidectomy should be performed.
  • 32. • Radioiodine Therapy- benefit to patients with differentiated thyroid cancer • External Beam Radiotherapy and Chemotherapy – External beam radiotherapy is occasionally required to control unresectable, locally invasive or recurrent disease – and to treat metastases in support bones to decrease the risk of fractures. • Single and multidrug chemotherapy has been used with little success in disseminated thyroid cancer. – Adriamycin and Taxol are the most frequently used agents.
  • 33. Medullary Carcinoma • MTCs account for about 5% of thyroid malignancies • arise from the parafollicular or C cells of the thyroid, which, in turn, are derived from the ultimobranchial bodies. • These cells are concentrated superolaterally in the thyroid lobes, which is where MTC usually develops. • C cells secrete calcitonin, a 32-amino-acid polypeptide that functions to lower serum calcium levels. (regulator of calcium metabolism) • Most MTCs occur sporadically. • However, approximately 25% occur within the spectrum of several inherited syndromes such as familial medullary thyroid cancer, MEN2A, and MEN2B. – All these variants are known to result secondary to germline mutations in the RET proto-oncogene.
  • 34. • Patients with MTC often present with a neck mass that may be associated with palpable cervical lymphadenopathy (15 to 20%). • Local pain or aching is more common in patients with these tumors, and local invasion may produce symptoms of dysphagia, dyspnea, or dysphonia. • Distant blood-borne metastases to the liver, bone (frequently osteoblastic), and lung occur later in the disease. • The female:male ratio is 1.5:1. • Most patients present between 50 and 60 years of age, although patients with familial disease present at a younger age. • Medullary thyroid tumors secrete – not only calcitonin and carcinoembryonic antigen (CEA), – but also other peptides such as calcitonin gene-related peptide (CGRP), histaminadases, prostaglandins E2 and F2, and serotonin.
  • 35. Pathology • MTCs are typically unilateral (80%) in patients with sporadic disease, • and multicentric in familial cases, with bilateral tumors occurring in up to 90% of familial patients. • Familial cases are also associated with C-cell hyperplasia, which is considered a premalignant lesion
  • 36. Diagnosis • The diagnosis of MTC is established – by history, physical examination, – raised serum calcitonin or CEA levels, – FNA cytology of the thyroid mass. • Attention to family history is important • because approximately 25% of patients with MTC have familial disease.
  • 37. • Total thyroidectomy is the treatment of choice for patients with MTC because of – the high incidence of multicentricity, – the more aggressive course, – 131I therapy is not usually effective. • External beam radiotherapy is controversial, but is recommended for patients with unresectable residual or recurrent tumor. • There is no effective chemotherapy regimen.
  • 38. Anaplastic Carcinoma • approximately 1% of all thyroid malignancies • Women are more commonly affected, and the majority of tumors present in the seventh and eighth decades of life. • The typical patient has a long-standing neck mass, which rapidly enlarges and may be painful. • Associated symptoms, such as dysphonia, dysphagia, and dyspnea, are common. • The tumor is large and may be fixed to surrounding structures or may be ulcerated
  • 39. • Lymph nodes usually are palpable at presentation. • Evidence of metastatic spread also may be present. • Diagnosis is confirmed by FNA biopsy revealing characteristic giant and multinucleated cells. • Incisional biopsy is occasionally needed to confirm the diagnosis and isthmusectomy is performed to alleviate tracheal compression.
  • 40. • Pathology – Gross - firm and whitish in appearance. – Microscopically, sheets of cells with marked heterogeneity are seen. • Treatment and Prognosis – This tumor is one of the most aggressive thyroid malignancies, with few patients surviving 6 months beyond diagnosis. – All forms of treatment have been disappointing.
  • 41. Lymphoma • A ccount for less than 1% of thyroid malignancies • most are of the non-Hodgkin's B-cell type. • Although the disease can arise as part of a generalized lymphomatous condition, most thyroid lymphomas develop in patients with chronic lymphocytic thyroiditis. • Patients usually present with symptoms similar to those of patients with anaplastic carcinoma, although the rapidly enlarging neck mass often is painless. • Patients may present with acute respiratory distress. • The diagnosis usually is suggested by FNA biopsy, although needle-core or open biopsy may be necessary for definitive diagnosis. • Staging studies should be obtained to assess the extent of extrathyroidal spread.
  • 42. Treatment and Prognosis • Respond rapidly to chemotherapy (CHOP—cyclophosphamide, doxorubicin, vincristine, and prednisone), which is also associated with improved survival. • Combined treatment with radiotherapy and chemotherapy is often recommended. • Thyroidectomy and nodal resection are used to alleviate symptoms of airway obstruction in patients who do not respond quickly to the above regimens, or in patients who have completed the regimen prior to diagnosis. • Prognosis depends on – the histologic grade of the tumor and – whether the lymphoma is confined to the thyroid gland or is disseminated. • The overall 5-year survival rate is about 50%; – patients with extrathyroidal disease have markedly lower survival rates.
  • 43. Metastatic Carcinoma • The thyroid gland is a rare site of metastases from other cancers, including kidney, breast, lung, and melanoma. • Clinical examination and a review of the patient's history often suggest the source of the metastatic disease, and FNA biopsy usually provides definitive diagnosis. • Resection of the thyroid, usually lobectomy, may be helpful in many patients, depending on the status of their primary tumor